Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 81Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Pharmathen SA

02 2Mankind Pharma

03 6A. Menarini

04 2ANI Pharmaceuticals Inc

05 2ARTHUR GRP

06 2Accord healthcare

07 2Actavis Inc

08 3Adamed Pharma

09 2Ajanta Pharma Limited

10 2Alkem Laboratories

11 2Amneal Pharmaceuticals

12 4Ascent Innovative Medicines

13 2Aurobindo Pharma Limited

14 3CHEMO

15 2Cadila Pharmaceuticals

16 2Chartwell Pharmaceuticals llc

17 2Cipla

18 3DOC Generici

19 3EG Spa

20 2Glenmark Pharmaceuticals

21 2Hetero Drugs

22 1Ind Swift Laboratories Limited

23 4Intas Pharmaceuticals

24 2Jubilant Generics

25 2KYE PHARMACEUTICALS INC.

26 3Krka

27 3LeBasi Pharmaceuticals CC

28 2MENARINI INTL

29 9Menarini

30 2Micro Labs Limited

31 2Novast Laboratories

32 1Pantson Pharma Pvt. Limited

33 2Piramal Pharma Solutions

34 2Rising Pharmaceuticals Inc

35 2ScieGen Pharmaceuticals

36 2Spil

37 2Sun Pharmaceutical Industries Limited

38 2Sunshine Lake Pharma

39 2Teva Pharmaceutical Industries

40 2Torrent Pharmaceuticals Limited

41 5Unichem Laboratories Limited

42 2Unichem Pharmaceuticals USA, Inc

43 2VKT Pharma

44 1Vega Biotech Pvt. Ltd.

45 1Viatris

46 2i3 Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info :

Registration Country : Greece

Ranolazine

Brand Name :

Dosage Form : Prolonged Release Tablet

Dosage Strength : 375MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

Pharmathen

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDelivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.

Regulatory Info : RX

Registration Country : USA

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2020-02-12

Application Number : 212284

Regulatory Info : RX

Registration Country : USA

Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info :

Registration Country : Greece

Ranolazine

Brand Name :

Dosage Form : Prolonged Release Tablet

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

Pharmathen

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info :

Registration Country : Greece

Ranolazine

Brand Name :

Dosage Form : Prolonged Release Tablet

Dosage Strength : 750MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

Pharmathen

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDelivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.

Regulatory Info : RX

Registration Country : USA

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM

Packaging :

Approval Date : 2020-02-12

Application Number : 212284

Regulatory Info : RX

Registration Country : USA

Company Banner

06

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2019-05-28

Application Number : 208862

Regulatory Info : RX

Registration Country : USA

blank

07

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM

Packaging :

Approval Date : 2019-05-28

Application Number : 208862

Regulatory Info : RX

Registration Country : USA

blank

08

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2019-05-28

Application Number : 210054

Regulatory Info : RX

Registration Country : USA

blank

09

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2020-11-30

Application Number : 209953

Regulatory Info : RX

Registration Country : USA

blank

10

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM

Packaging :

Approval Date : 2020-11-30

Application Number : 209953

Regulatory Info : RX

Registration Country : USA

blank

11

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2021-03-11

Application Number : 207690

Regulatory Info : DISCN

Registration Country : USA

blank

12

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM

Packaging :

Approval Date : 2021-03-11

Application Number : 207690

Regulatory Info : DISCN

Registration Country : USA

blank

13

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2022-12-23

Application Number : 209081

Regulatory Info : RX

Registration Country : USA

blank

14

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM

Packaging :

Approval Date : 2022-12-23

Application Number : 209081

Regulatory Info : RX

Registration Country : USA

blank

15

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2013-07-29

Application Number : 201046

Regulatory Info : RX

Registration Country : USA

blank

16

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM

Packaging :

Approval Date : 2013-07-29

Application Number : 201046

Regulatory Info : RX

Registration Country : USA

blank

17

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number : 208174

Regulatory Info :

Registration Country : USA

blank

18

AMWC Asia-TDAC
Not Confirmed
arrow
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANOLAZINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1000MG

Packaging :

Approval Date :

Application Number : 208174

Regulatory Info :

Registration Country : USA

blank

19

MENARINI INTL

Country
AMWC Asia-TDAC
Not Confirmed
arrow

MENARINI INTL

Country
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANEXA

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2007-02-12

Application Number : 21526

Regulatory Info : DISCN

Registration Country : USA

blank

20

MENARINI INTL

Country
AMWC Asia-TDAC
Not Confirmed
arrow

MENARINI INTL

Country
arrow
AMWC Asia-TDAC
Not Confirmed

RANOLAZINE

Brand Name : RANEXA

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2006-01-27

Application Number : 21526

Regulatory Info : DISCN

Registration Country : USA

blank